title: Value of CA 15-3 determination in the initial management of breast cancer patients.
authors.forename: S
authors.initials: S
authors.lastname: Chourin
authors.forename: D
authors.initials: D
authors.lastname: Georgescu
authors.forename: C
authors.initials: C
authors.lastname: Gray
authors.forename: C
authors.initials: C
authors.lastname: Guillemet
authors.forename: A
authors.initials: A
authors.lastname: Loeb
authors.forename: C
authors.initials: C
authors.lastname: Veyret
authors.forename: J-P
authors.initials: JP
authors.lastname: Basuyau
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000276:immunology* / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D005260:Female; D006801:Humans; D053208:Kaplan-Meier Estimate; D018396:Mucin-1 / Q000032:analysis*; D009367:Neoplasm Staging; D018579:Patient Selection; D011237:Predictive Value of Tests; D016016:Proportional Hazards Models; D018570:Risk Assessment; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D014408:Biomarkers, Tumor; C060192:MUC1 protein, human; D018396:Mucin-1